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ABSTRACT 
Aim- The main aim of the study is to evaluate the Antidiabetic and antihyperlipidemic activity of Centella asiatica in diabetic animals. Material & 
Methods- Different extracts were prepared by successive solvent extraction methods. Diabetes was induced by single injection of STZ in normal 
animals and diabetes was confirmed by glucose oxidation methods. The treatments of different extracts were given from third day to 21st day 
and at the end of 22nd day, blood sample was withdrawn and different lipid level was determined.  Result- Among all the extracts, 
dichloromethane extracts showed significantly activity in reducing blood glucose level and decreased the VLDL, LDL, TC, Triglycerides and 
significantly increased the HDL-C level. Conclusion- The results obtained in this study have shown that dichloromethane extract shown 
significant Antidiabetic and antihyperlipidemic activity. Further detailed studies are required to isolate the active phytoconstituents by 
bioactivity guided isolation techniques responsible for anti-diabetic and hypolipidemic activity. The present findings are significant for the 
development of alternative, inexpensive and safer therapy for the treatment of diabetes mellitus and hyperlipidemic. 
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INTRODUCTION 
Phytochemicals from medicinal plants serve as lead 
compounds in drug discovery and design. Medicinal plants 
are rich source of novel drugs that forms the ingredients in 
Traditional Systems of medicine, modern medicines, 
neutraceuticals, food supplements, folk medicines, 
pharmaceutical intermediates, bioactive principles and lead 
compounds in synthetic drugs1. 
Herbal extracts produce diverse range of natural products 
including isoflavonoids, indoles, phytosterols, 
polysaccharides, sesquiterpenes, alkaloids, glucans and 
tannins which exhibit complex pharmacological properties. 
Therefore, contrary to the allopathic medicines, herbal 
therapy has emerged as a promising alternative with least 
toxicities and fewer complications. There is an over growing 
interest in investigating different medicinal plants in order 
to identify their potential therapeutic applications2,3. 
As per the literature review, it has been observed that 
Centella asiatica Linn. (Leaves) is listed among the various 
medicinal plants widely been used as a antibacterial, 
demulcent, bitter tonic, laxative, carminative, refrigerant, 
and febrifuge, diuretic, useful in chronic cystitis, gonorrhea 
and cadiotonic, acute-chronic inflammatory conditions and 
in treatment of diabetes mellitus, hyperlipidemic conditions, 
liver diseases and as a antiulcer4. 
In the absence of any scientific evidence for their anti-
diabetic and antihyperlipidemic activity in animals, so there 
is a need in scientifically establishing the anti-diabetic and 
antihyperlipidemic activity so that we are able to come up 
with a more effective and potent extracts fractions or 
bioactive phytoconstituents with fewer side effects in 
comparison with existing synthetic drugs.  
MATERIAL & METHODS 
Collection and authentication of the plant leaves- 
The fresh leaves of Centella asiatica Linn. was collected from 
outfield during the month of September that shows the green 
color with rough surface. The plant leaves were washed 
thoroughly in tap water, dried in shade, finely powdered and 
used for successive extraction methods. Plant was identified 
by Dr. Anurag Titov, Professor, Department of Botany, Govt. 
Madhav Sciences, PG College, Dewas Road, Ujjain and 
herbarium specimen was submitted in Department of Botany 
for future references. 
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Extraction Method 
The extraction was done by following continuous or 
extraction procedure. Powdered material (stem bark) was 
packed in soxhlet apparatus. The drug was defatted with 
petroleum ether (60-80°C) for about 30-35 complete cycles. 
Defatted material was subjected to further extraction 
process by dichloromethane, methanol and water. All the 
extracts were concentrated under vacuum. The yield values 
and other physical properties were observed5. 
The % Yield of the Petroleum ether, chloroform, Methanol, & 
Aqueous extract of was calculated by using the following 
formula. 
                               Weight of Extract (gm) 
% Yield = -------------------------------------------------------- x 100 
                Weight of powder drug Taken for extraction 
Qualitative Phytochemical Screening 
Preliminary phytochemical screening was performed for 
presence of fatty acids, steroids, terpenoids, alkaloids, 
flavonoids, phenolic compounds, glycosides etc in all the 
extracts6,7.  
Antidiabetic study of different extracts 
Animals 
Wistar Albino rats of either sex (150 to 200 g) were 
purchased from the CPCSEA approved vendor New Delhi. 
Commercial pellet diet (MFD, by Nav Maharashtra Chakan 
Oil Mills ltd., New Delhi, India) and water were provided ad 
libitum throughout the course of study. All the experimental 
trial was carried out in agreement with the CPCSEA 
guidelines. The study designs were permitted by the 
Institutional Animal Ethical Committee of Oriental College of 
Pharmacy and Research, Oriental University, Indore (MP), 
India.  
Selection of Dose 
Acute oral toxicity test was carried out according to the 
OECD guideline No. 423. Wistar Albino Rats were kept for 
overnight fasting prior to drug administration. A total of 
three animals were used, which received a single oral dose in 
2000 mg/kg, body weight of different extracts. The animals 
were observed for a period of 24 hr for the changes in 
behavior, hypersensitivity reactions etc. Mortality, if any, 
was determined over a period of 2 weeks. Hence in our 
studies we selected 1/10 and 1/5th dose i.e. 200 and 400 
mg/kg dose. 
Preparation of Doses 
Doses equivalent to 200 mg and 400 mg of the crude drug 
per kilogram body weight were calculated, and suspended in 
1% w/v tween 80 solutions for the experiment. 
Streptozotocin (STZ) induced diabetes in rats  
After fasting 18 hours, the rats were injected intraperitoneal 
injection through tail vein with a single dose of 40 mg/kg 
Streptozocin (Sigma, St. Louis, Mo, USA), freshly dissolved in 
citrate buffer (pH 4.5). After injection, the rats had free 
access to food and water and were given 5% glucose solution 
to drink overnight to counter hypoglycemic shock. Diabetes 
in rats was observed by moderate Polydipsia and marked 
Polyuria. The diabetes was confirmed by estimating the 
blood glucose level after 3 days by glucometer based on 
glucose oxidation method. Rats having blood glucose level 
more than 250 mg/dl were selected for further study9. In 
order to assess the anti-diabetic activity, the animals were 
divided in eleven groups of six animals in each group. 
Group 1: Normal control, 0.9% NaCl-treated animals 
Group 2: Diabetic control, STZ -treated rats (40 mg/kg body 
weight) 
Group 3: Treated with Pet. Ether extract of leaves of CA (200 
mg/kg body weight) 
Group 4: Treated with Pet. Ether extract of leaves of CA (400 
mg/kg body weight) 
Group 5: Treated with dichloromethane extract of leaves of 
CA (200 mg/kg body weight) 
Group 6: Treated with dichloromethane extract of leaves of 
CA (400 mg/kg body weight) 
Group 7: Treated with methanolic extract of leaves of CA 
(200 mg/kg body weight) 
Group 8: Treated with methanolic extract of leaves of CA 
(400 mg/kg body weight) 
Group 9: Treated with aqueous extract of leaves of CA (200 
mg/kg body weight) 
Group 10: Treated with aqueous extract of leaves of CA (400 
mg/kg body weight) 
Group 11: Standard drug, Glibenclamide-treated rats (5 
mg/kg body weight) 
The test drug and reference drug was administered orally at 
two dose level for a period of 21 days from starting day of 
diabetes.  
Blood collection and glucose level estimations in serum  
On 22nd day, fasting blood samples were collected from the 
tail vein of all the groups of rats. Whole blood was collected 
for estimation of blood glucose by using the glucometer 
(Easy Gluco, Morepen Laboratories Ltd.; New Delhi)10. 
Determination of various lipids 
Then serum samples were also used to analyze for serum 
Total Cholesterol (TC), Triglycerides (TG), High Density 
Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein 
Cholesterol (LDL-C) and Very Low Density Lipoprotein 
Cholesterol (VLDL-C)11. 
Statistical Analysis  
Data were expressed as the mean ± standard error of mean 
(S.E.M.) of the means and statistical analysis was carried out 
employing one-way ANOVA. Differences between the data 
were considered significant at P < 0.05. 
RESULTS 
Phytochemical Screening  
Phytochemical screening of different extracts showed the 
presence of different phytoconstituents. 
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Table 1: Preliminary Phytochemical test for different extracts of Centella asiatica 
S.No. Test Petroleum ether Dichloromethane Methanol Aqueous 
1. Carbohydrate 
 Molish test 
 Felling test 
 
- 
- 
 
- 
- 
 
+ 
+ 
 
+ 
+ 
2. Glycosides 
 Bronteger test 
 
- 
 
- 
 
+ 
 
+ 
3. Alkaloid 
 Mayer test 
 Hager test 
 
- 
- 
 
+ 
+ 
 
+ 
+ 
 
- 
- 
4. Phytosterol + Triterpinoids 
 Salkowaski  test 
 
- 
 
+ 
 
+ 
 
- 
5. Protein + Amino acid 
 Biuret test 
 Ninhydrin test 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
6. Phenolic test 
 Ferric test 
 Lead acetate test 
 
- 
- 
 
+ 
+ 
 
+ 
+ 
 
- 
- 
7. Flavonoids 
 Alkaline test  
 
- 
 
- 
 
+ 
 
+ 
8. Saponin 
 Foam test  
 
- 
 
- 
 
+ 
 
+ 
Note: (+) ve indicates positive result, whereas (–) ve indicates negative result 
 
Antidiabetic study of leaves of Centella asiatica Linn. 
Effect on different extracts on Blood glucose level in 
diabetic rats 
The induction of diabetes with streptozotocin increases the 
blood glucose level significantly (p<0.001) in group II rats as 
compared to normal rats. In 21 day study glibenclamide the 
standard drug restored the blood glucose highly significantly 
with the p<0.001 in 14 days whereas dichloromethane 
extract (200 & 400 mg/kg) reduced the glucose level 
moderately and highly significant with p<0.01 & p<0.001. 
Among all the extracts aqueous extracts didn’t show any 
significant decrease in glucose levels. The results are shown 
in Table No 2. 
  
Table 2: Effect of different extracts on glucose level in streptozotocin induced diabetic rats 
Grou
p No 
Group Blood Sugar level 
Long Term Study (Days) 
Before 
inducing 
Diabetes 
3 7 14 21 
I Normal control 80.3 ± 3.22 81.4 ± 3.44 81.6 ± 2.47 82.9 ± 3.21 82.33 ± 2.55 
II Diabetic control 82.4 ±0.81 242.7 ± 3.33 274.2 ± 3.44*** 269.3 ±3.37 *** 293.1 ± 4.31***  
III Pet. Ether extract 
(200 mg/kg) 
80.4 ± 3.32 242.6 ± 3.56 237.2 ± 3.33** 235.3± 3.44**  225.6 ±  3.20** 
IV Pet. Ether extract 
(400 mg/kg) 
83.77 ± 2.58 242.4 ± 3.74 224.3 ± 2.45** 216.3± 3.89**  205.4 ± 3.44**  
V DCM extract (200 
mg/kg) 
82.33 ± 3.39 243.4 ± 3.45 218.4 ± 2.32*** 204.8±3.58*** 197.5±  3.55***  
VI DCM extract (400 
mg/kg) 
81.33 ± 3.39 244.6 ± 3.44 206.3 ± 3.44***  193.6±3.88*** 176.3±  2.82*** 
VII Methanolic extract  
(200 mg/kg) 
81.4 ± 2.33 244.6 ± 3.41 223.9 ± 3.77 217.2± 2.44** 214.6 ± 2.80** 
VIII Methanolic extract 
(400 mg/kg) 
80.6 ± 3.44 242.6 ± 3.41 221.2 ± 3.99 212.8± 2.49**  209.2 ± 3.44** 
IX Aqueous extract 
(200 mg/kg) 
82.4 ±2.93 240.7 ± 2.33 271.8 ± 2.35 271.3 ±3.66 283.1 ± 4.34  
X Aqueous extract 
(400 mg/kg) 
82.1 ±3.81 241.7 ± 3.44 268.2± 4.33 265.3 ±3.15 262.1 ± 3.45 
XI Glibernclamide  
(5 mg/kg) 
81.25 ± 3.44 242.1 ± 2.88 197.4 ± 3.51** 168.3± 2.19*** 158.2± 3.99*** 
Where- *p<0.05, **p<0.01, ***p<0.001 compared with diabetic control vs treated groups 
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Effect of different extracts on lipid level  
Untreated diabetic rats showed significant hyper-
cholesterolemia, hyper triglyceridemia, elevated LDL-
Cholesterol, VLDL-Cholesterol and decrease in HDL –
Cholesterol in comparison to that of normal group. 
Dichloromethane or DCM extract of leaves showed a very 
good effect on lipid profile. It showed highly significant 
(p<0.001) effect on lipid profile in comparison to that of 
diabetic group. Dichloromethane extract also showed a 
highly significant effect on various lipids and also increased 
HDL level as compared to disease group or diabetic animals.  
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Figure 1: Effect of different extracts on Total Cholesterol 
level 
N
C
D
C
P
E 
20
0
P
E 
40
0
D
C
M
 2
00
D
C
M
 4
00
M
 2
00
M
 4
00
A
 2
00
A
 4
00 S
 5
0
50
100
150
Groups
T
ri
g
ly
c
e
ri
d
e
s
 (
m
g
/d
l)
 
Figure 2: Effect of different extracts on Triglycerides level 
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Figure 3: Effect of different extracts on LDL-C level 
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Figure 4: Effect of different extracts on VLDL-C level 
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Figure 5: Effect of different extracts on HDL-C level 
DISCUSSION 
Preliminary phytochemical evaluation reported that 
existence of triterpenoids, steroids and fatty acids, saponins, 
phytosterols, flavonoids, phenols, alkaloids, and glycosides.  
Toxicity study of a new compound must be done accurately 
for the selection of the dose, used for its pharmacological 
screening.  
In this study, all the extracts at the dose of 2000mg/kg 
indexed neither visible signs of toxicity nor mortality and 
observations did not point out any proofs of substance 
related toxicity. Based on the LD50 value, 1/5th and 1/10th 
(200 & 400 mg/kg) of its value was chosen for 
pharmacological studies. 
The islet β-cells are susceptible to damage caused by oxygen 
free radicals 12,13 since the antioxidant defense system is 
weak under diabetic condition. The levels of antioxidant 
defense system are altered in streptozotocin-induced 
diabetic rats, which are in good correlation with the present 
observation. Non protein thiols like glutathione are one of 
the important primary defenses that counteract the 
oxidative stress. Decreased levels of serum glutathione in 
streptozotocin diabetic rats, which is in consistent with 
earlier reports14 . 
The dichloromethane extract of Centella asiatica produced a 
marked decrease in blood glucose levels at 200 mg/kg and 
400 mg/kg body weight in streptozotocin-diabetic rats after 
21 days treatment. The Antidiabetic effect may be due to 
increased release of insulin from the existing β-cells of 
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pancreas similar to that observed after glibenclamide 
administration.  
From the previous reported literature, Triterpenoids, 
flavonoids and phenolic compounds are responsible for anti-
diabetic & hyperlipidemic effect. So probably, overall effect 
of plant may be due to presence of terpenoids in 
dichloromethane extract.  
STZ-diabetic rats showed increase in plasma cholesterol and 
triglyceride concentrations15 which may contribute to the 
development and progression of micro and macro-vascular 
complications It has been known that hyperlipidemia 
induced with hyperglycemia is an important determinant of 
cardiovascular mortality and is linked to diabetes mellitus. 
Hence, attenuation of hyperglycemia or glycation of 
lipoproteins, enzymes and receptors involved in lipid 
metabolism can decrease the risk of cardiovascular death in 
diabetic patients16. 
The marked hyperlipidemia that characterizes the diabetic 
state may, therefore, be regarded as a consequence of 
uninhibited actions of lipolytic hormones on the fat deposits. 
Studies on STZ-induced diabetes in experimental animals 
have suggested that an increase in circulatory VLDL and 
their associated triglycerides are largely due to defective 
clearance of these particles from the circulation. 
Normally circulating LDL-C undergoes reuptake in the liver 
via specific receptors and gets cleared from the circulation 
(Lusis, 2000). HDL-C is protective by reversing cholesterol 
transport, inhibiting the oxidation of LDL-C and by 
neutralizing the atherogenic effects of oxidized LDL-C.  
In diabetic rats treated with dichloromethane extract 
showed an elevation in HDL-C and reduction in LDL-C and 
VLDL-C.  
CONCLUSION 
The results obtained in this study have shown that 
dichloromethane extract shown significant Antidiabetic and 
antihyperlipidemic activity. Further detailed studies are 
required to isolate the active phytoconstituents by 
bioactivity guided isolation techniques responsible for anti-
diabetic and hypolipidemic activity. The present findings are 
significant for the development of alternative, inexpensive 
and safer therapy for the treatment of diabetes mellitus and 
hyperlipidemic. 
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